Steven Paul

Education & Training

---

• M.D.: Tulane University, 1975
• M.S.: Tulane University, 1975
• B.S.: Tulane University, 1972

View clinician profile

Recent Publications

---

• Author Correction: Novel drug treatments for schizophrenia (Nature Reviews Drug Discovery, (2026), 10.1038/s41573-025-01335-w)

  Coyle, J. T. & Paul, S. M., Apr 2026, In: Nature Reviews Drug Discovery. 25, 4, p. 331 1 p.

• Novel drug treatments for schizophrenia

  Coyle, J. T. & Paul, S. M., Apr 2026, In: Nature Reviews Drug Discovery. 25, 4, p. 310-330 21 p.

• Targeting muscarinic receptors for treating schizophrenia

  Paul, S. M. & Yohn, S. E., Jan 2026, In: Neurotherapeutics. 23, 1, e00839.

• Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia

  Conn, P. J. & Paul, S. M., 2026, In: Annual review of medicine. 77, 1, p. 399-413 15 p.

• 25-hydroxycholesterol promotes brain cytokine production and leukocyte infiltration in a mouse model of lipopolysaccharide-induced neuroinflammation

  Romero, J., Toral-Rios, D., Yu, J., Paul, S. M. & Cashikar, A. G., Dec 2024, In: Journal of Neuroinflammation. 21, 1, 251.

See more publications